Literature DB >> 3508523

N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.

A J Nazarali1, G B Baker, R T Coutts, T F Wong.   

Abstract

The disposition of the N-cyanoethyl analogue of tranylcypromine (TCP) and the TCP formed from it have been studied in the rat brain following intraperitoneal (ip) administration (0.1 mmol/kg) and the resultant data compared with those obtained following an equimolar dose of TCP. Brain concentrations of the neurotransmitter amines dopamine (DA) and noradrenaline (NA) have also been determined, as well as the percentage inhibition of monoamine oxidase (MAO) types A and B. Our results indicate that the N-cyanoethyl analogue may be a useful prodrug of TCP, providing lower but more sustained concentrations of TCP in brain. Brain levels of DA were increased in a similar pattern after CE-TCP or TCP. Brain levels of NA were decreased by TCP at most time intervals, while CE-TCP produced a much less pronounced effect. Both CE-TCP and TCP inhibited MAO-A and MAO-B, with maximum inhibition occurring 60 min after CE-TCP dosing and 30 min after dosing with TCP, times at which brain concentrations of CE-TCP and TCP were at the maximum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3508523     DOI: 10.1023/a:1016417624741

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE.

Authors:  R J WURTMAN; J AXELROD
Journal:  Biochem Pharmacol       Date:  1963-12       Impact factor: 5.858

2.  Comparison of the apparent antidepressant activity of (-) and (+) tranylcypromine in an animal model.

Authors:  J A Fuentes; M A Oleshansky; N H Neff
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

3.  The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution and metabolism of (plus or minus)-ethylamphetamine in man.

Authors:  A H Beckett; E V Shenoy; J A Salmon
Journal:  J Pharm Pharmacol       Date:  1972-03       Impact factor: 3.765

4.  [Clinical experimentation with fenproporex in the treatment of obesity. Apropos of 40 cases].

Authors:  H Warembourg; J Jaillard
Journal:  Lille Med       Date:  1968-03

5.  Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.

Authors:  E D Hendley; S H Snyder
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

6.  Tranylcypromine: effects on norepinephrine metabolism in rat brain.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

7.  A method for measurement of tranylcypromine in rat brain regions using gas chromatography with electron capture detection.

Authors:  D G Calverley; G B Baker; R T Coutts; W G Dewhurst
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

8.  [Treatment of obese female patients with fenproporex within the framework of gynecologic practice].

Authors:  G Hertel; W Fallot-Burghardt
Journal:  Fortschr Med       Date:  1978-12-14

9.  Determination of picogram levels of brain catecholamines and indoles by a simplified liquid chromatographic electrochemical detection method.

Authors:  C Kim; C Campanelli; J M Khanna
Journal:  J Chromatogr       Date:  1983-12-30

10.  Amphetamine in rat brain after intraperitoneal injection of N-alkylated analogues.

Authors:  A J Nazarali; G B Baker; R T Coutts; F M Pasutto
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

View more
  5 in total

1.  "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

Authors:  M T Martin-Iverson; N Yamada; A W By; B A Lodge
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186

2.  Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  T S Rao; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

Authors:  Martin Weber; Sonja Talmon; Ilka Schulze; Christine Boeddinghaus; Gerhard Gross; Hans Schoemaker; Karsten M Wicke
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

4.  Para-hydroxytranylcypromine: presence in rat brain and heart following administration of tranylcypromine and an N-cyanoethyl analogue.

Authors:  A J Nazarali; G B Baker; R T Coutts; A J Greenshaw
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

5.  Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  G B Baker; R T Coutts; T S Rao
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.